Supramolecular Nanoplatforms with Activable Ultrasound and Magnetic Resonance Imaging for Cancer Diagnosis and Therapy
Source abstract
Abstract
Abstract Excellent multifunctional platforms for cancer diagnosis and treatment are highly desirable. Herein, multifunctional nanocomposites are constructed by utilizing Mn 2+ to coordinate to the imidazole moiety anchored on CuO 2 nanoparticles through cyclodextrin‐adamantane interaction. The encapsulated CuO 2 nanoparticles (NPs) can generate hydrogen peroxide (H 2 O 2 ) at tumor sites under acidic conditions upon decomposition, which is further turned into oxygen (O 2 ) under Mn 2+ catalysis, facilitating both ultrasound and magnetic resonance imaging (MRI). Moreover, the proposed nanomedicine enhances reactive oxygen species (ROS) generation and depletes glutathione (GSH), leading to increased lipid peroxidation (LPO) and effective ferroptosis‐mediated cancer therapy. Such a strategy presents a promising approach for the development of theranostics for imaging‐guided tumor therapy.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery · Advanced Nanomaterials in Catalysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
State Key Laboratory of Chemical Resource Engineering College of Chemistry Beijing University of Chemical Technology Beijing 100029 P. R. China
Funding
National Natural Science Foundation of China · Fundamental Research Funds for the Central Universities
References (50)
Show source-provided references
1. 10.1038/d41586-020-00849-010.1038/d41586-020-00849-0 ↗
2. 10.1038/nrc.2016.10810.1038/nrc.2016.108 ↗
3. 10.1021/acs.chemrev.3c0006210.1021/acs.chemrev.3c00062 ↗
4. 10.1016/j.ccr.2023.21565410.1016/j.ccr.2023.215654 ↗
5. 10.1002/adma.20231216910.1002/adma.202312169 ↗
6. 10.1016/j.ccr.2023.21517810.1016/j.ccr.2023.215178 ↗
7. 10.1039/D2CS00352J10.1039/D2CS00352J ↗
8. 10.1039/D4SC03643C10.1039/D4SC03643C ↗
9. 10.1002/adfm.20221274010.1002/adfm.202212740 ↗
10. 10.1002/smll.20210371210.1002/smll.202103712 ↗
11. 10.1002/smll.20220682110.1002/smll.202206821 ↗
12. 10.1021/acs.nanolett.4c0392910.1021/acs.nanolett.4c03929 ↗
13. 10.1016/j.chempr.2022.06.00610.1016/j.chempr.2022.06.006 ↗
14. 10.1021/acsnano.3c1230510.1021/acsnano.3c12305 ↗
15. 10.1021/acsami.3c1073310.1021/acsami.3c10733 ↗
16. 10.1021/acsami.4c1471510.1021/acsami.4c14715 ↗
17. 10.1016/j.ccr.2024.21630310.1016/j.ccr.2024.216303 ↗
18. 10.1002/smll.20240687910.1002/smll.202406879 ↗
19. 10.1002/adhm.20200154910.1002/adhm.202001549 ↗
20. 10.1039/D4CS00599F10.1039/D4CS00599F ↗
21. 10.1038/s41570-021-00277-210.1038/s41570-021-00277-2 ↗
22. 10.1002/smtd.20170017310.1002/smtd.201700173 ↗
23. 10.1016/j.jconrel.2022.11.02110.1016/j.jconrel.2022.11.021 ↗
24. 10.1186/s40580-021-00287-210.1186/s40580-021-00287-2 ↗
25. 10.1002/adhm.20170051410.1002/adhm.201700514 ↗
26. 10.1021/acsnano.8b0835910.1021/acsnano.8b08359 ↗
27. 10.1021/acsnano.9b0873710.1021/acsnano.9b08737 ↗
28. 10.1016/j.cej.2023.14476610.1016/j.cej.2023.144766 ↗
29. 10.1021/jacs.0c1009810.1021/jacs.0c10098 ↗
30. 10.1021/nn506210a10.1021/nn506210a ↗
31. 10.1002/anie.20090384110.1002/anie.200903841 ↗
32. 10.1002/adfm.20210500110.1002/adfm.202105001 ↗
33. 10.1002/adfm.20160321210.1002/adfm.201603212 ↗
34. 10.1021/acsnano.7b0377210.1021/acsnano.7b03772 ↗
35. 10.1021/acsnano.3c1261510.1021/acsnano.3c12615 ↗
36. 10.1021/acsnano.1c0789310.1021/acsnano.1c07893 ↗
37. 10.1021/acsnano.4c1375310.1021/acsnano.4c13753 ↗
38. 10.1016/j.compositesb.2021.10936410.1016/j.compositesb.2021.109364 ↗
39. 10.1021/jacs.9b0345710.1021/jacs.9b03457 ↗
40. 10.1016/j.nantod.2021.10133710.1016/j.nantod.2021.101337 ↗
41. 10.1021/acsnano.1c0917110.1021/acsnano.1c09171 ↗
42. 10.1016/j.cej.2023.14811310.1016/j.cej.2023.148113 ↗
43. 10.1016/j.carbpol.2020.11687110.1016/j.carbpol.2020.116871 ↗
44. 10.1002/adhm.20230088310.1002/adhm.202300883 ↗
45. 10.1002/smll.20220033010.1002/smll.202200330 ↗
46. 10.1002/adma.20180615810.1002/adma.201806158 ↗
47. 10.1039/D1CS00821H10.1039/D1CS00821H ↗
48. 10.1016/j.ccr.2022.21491910.1016/j.ccr.2022.214919 ↗
49. 10.1002/anie.20231836810.1002/anie.202318368 ↗
50. 10.1021/acs.accounts.3c0023410.1021/acs.accounts.3c00234 ↗